OBJECTIVE To investigate the influence of O-(4-ethoxyl-butyl)-berbamine (EBB) on the expression of cyclin B1 and cdc2-p34 in the human drug-resistant breast can
BACKGROUND:Highly selective cyclooxygenase-2(COX-2)inhibitors have recently been approved for the treatment of colon cancer,breast cancer,urinary bladder cancer